Susquehanna International Group, LLP Cytokinetics Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $1.57 Million - $1.85 Million	30,700 Added 10.59%	320,500 $16.9 Million
Q2 2024 Aug 15, 2024	SELL	$47.86 - $75.05 $31.4 Million - $49.2 Million	-655,900 Reduced 69.36%	289,800 $15.7 Million
Q1 2024 May 07, 2024	SELL	$63.75 - $108.06 $65.7 Million - $111 Million	-1,030,000 Reduced 52.13%	945,700 $66.3 Million
Q4 2023 Feb 14, 2024	BUY	$26.88 - $83.49 $47.2 Million - $146 Million	1,754,600 Added 793.58%	1,975,700 $165 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $5.96 Million - $7.41 Million	202,300 Added 1076.06%	221,100 $6.51 Million
Q2 2023 Aug 11, 2023	SELL	$32.62 - $40.75 $404,487 - $505,300	-12,400 Reduced 39.74%	18,800 $613,000
Q1 2023 May 16, 2023	SELL	$33.36 - $45.71 $460,368 - $630,798	-13,800 Reduced 30.67%	31,200 $1.1 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $1.1 Million - $1.57 Million	30,800 Added 216.9%	45,000 $2.06 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $169,576 - $239,888	-4,400 Reduced 23.66%	14,200 $688,000

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.44B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.